{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:36:06Z","timestamp":1791822966946,"version":"4.3.4"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Age-related accumulation of somatic mutations in hematopoietic stem and progenitor cells (HSPCs), causing clonal hematopoiesis (CH), often precedes the development of hematologic malignancies. Chronic inflammation and aberrant cytokine expression that are common in aging, contribute to clonal expansion and genomic instability. Acute myeloid leukemia (AML) is an (epi)genetically and physiologically diverse malignancy, characterized by clonal proliferation and incomplete differentiation of HSPCs. The innate immune system, with pattern recognition receptors (PRRs), plays a pivotal role in maintaining hematopoietic homeostasis. Dysregulated signaling through PRRs disrupts hematopoiesis, fostering malignant cell proliferation. In addition, cytokines and interferons exert multifaceted effects on HSPCs, impacting their proliferation, differentiation, and survival. Therapeutic approaches targeting innate immune pathways, offer promising avenues for treating hematologic malignancies. Understanding the intricate crosstalk between innate immunity and hematopoiesis would provide insights into novel therapeutic strategies for combating hematologic malignancies, offering hope for improved patient outcomes and survival. In this review, we discuss about the malfunctioning innate immune-inflammatory axes in the context of abnormal hematopoiesis and the therapeutic approaches that are utilizing\/targeting these pathways with efficacy. This review delves into the derangements of innate immune and inflammatory pathways implicated in the development of AML and myelodysplastic syndromes (MDS), shedding light on the therapeutic strategies targeting these pathways.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1660709","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:17:26Z","timestamp":1760588246000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Innate immune-inflammatory signaling milieu in myeloid leukemia and aging-associated clonal hematopoiesis pathologies"],"prefix":"10.3389","volume":"16","author":[{"given":"Satyaki","family":"Bhowmik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab4082","article-title":"Somatic mutation in cancer and normal cells","volume":"349","author":"Martincorena","year":"2015","journal-title":"Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat Gene"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.11.014","article-title":"Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis","volume":"25","author":"Osorio","year":"2018","journal-title":"Cell Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"366"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative neoplasms and inflammation: whether to target the Malignant clone or the inflammatory process or both","volume":"30","author":"Koschmieder","year":"2016","journal-title":"Leuk"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-777029","article-title":"The Journal of the American Society of Hematology, DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000989","article-title":"Clonal hematopoiesis and nonhematologic disorders","volume":"136","author":"Jaiswal","year":"2020","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"The Journal of the American Society of Hematology, Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000489042","article-title":"Diagnostic criteria, separation from MDS and clinical implications","volume":"86","author":"Valent","year":"2019","journal-title":"Pathobiol: J Immunopathol Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/asheducation-2015.1.299","article-title":"The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)","volume":"2015","author":"Malcovati","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation.V2012.1.485.3798522","article-title":"Low blood counts: immune mediated, idiopathic, or myelodysplasia","volume":"2012","author":"Valent","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19008","article-title":"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions","volume":"8","author":"Valent","year":"2017","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-672659","article-title":"Cytopenias + mutations - dysplasia = what","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"New Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-663237","article-title":"Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression","volume":"126","author":"Cargo","year":"2015","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database","volume":"30","author":"Schanz","year":"2012","journal-title":"merge"},{"key":"B19","article-title":"Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases","volume":"7","author":"Morel","year":"1993","journal-title":"Leuk"},{"key":"B20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood.2019000942","article-title":"Genetics of progression from MDS to secondary leukemia","volume":"136","author":"Menssen","year":"2020","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exphem.2020.09.189","article-title":"Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy","volume":"92","author":"Boila","year":"2020","journal-title":"Exp Hematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"New England J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301689","article-title":"Medicine, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"C.G.A.R.N.J.N.E","year":"2013","journal-title":"New England J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"New England J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0492","article-title":"The Journal of the American Society of Hematology, The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.2011.34.8540","article-title":"Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes","volume":"29","author":"Kristinsson","year":"2011","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nat"},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2013.10.009","article-title":"Structures of pattern recognition receptors reveal molecular mechanisms of autoinhibition, ligand recognition and oligomerization","volume":"26","author":"Chuenchor","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nat"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-\u03baB and I\u03baB proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-486142","article-title":"The Journal of the American Society of Hematology, Deletion of the NF-\u03baB subunit p65\/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function","volume":"121","author":"Stein","year":"2013","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/145293","article-title":"Pathogenesis of myeloproliferative neoplasms: role and mechanisms of chronic inflammation","volume":"2015","author":"Hermouet","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e90972","DOI":"10.1371\/journal.pone.0090972","article-title":"Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound","volume":"9","author":"Karthik","year":"2014","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.68","article-title":"G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling","volume":"28","author":"Schuettpelz","year":"2014","journal-title":"Leuk"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.immuni.2014.12.010","article-title":"NOD1 and NOD2: signaling, host defense, and inflammatory disease","volume":"41","author":"Caruso","year":"2014","journal-title":"Immun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2018-99-117076","article-title":"Inflammasome-mediated regulation of hematopoiesis in the vertebrate embryo","volume":"132","author":"Frame","year":"2018","journal-title":"Nat"},{"key":"B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1314424","DOI":"10.1080\/2162402X.2017.1314424","article-title":"Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications","volume":"6","author":"Musella","year":"2017","journal-title":"Oncoimmunology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I-and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/cancers13051037","article-title":"Type I and II interferons in the anti-tumor immune response","volume":"13","author":"Fenton","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"904908","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Duchosal","year":"2009","journal-title":"Nat"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131043","article-title":"Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons","volume":"211","author":"Pietras","year":"2014","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.06.004","article-title":"Novel roles of complement in T effector cell regulation","volume":"217","author":"Heeger","year":"2012","journal-title":"Immunobiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nri3761","article-title":"Complement\u2014tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00001","article-title":"Keeping it all going\u2014Complement meets metabolism","volume":"8","author":"Kolev","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053245","article-title":"Complement and the regulation of T cell responses","volume":"36","author":"West","year":"2018","journal-title":"Annual Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12015-025-10856-1","article-title":"Reports, complosome regulates hematopoiesis at the mitochondria level","volume":"21","author":"Konopko","year":"2025","journal-title":"Stem Cell Rev Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-730556","article-title":"The Journal of the American Society of Hematology, The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MOH.0000000000000148","article-title":"Fight or flight-regulation of emergency hematopoiesis by pyroptosis and necroptosis","volume":"22","author":"Croker","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biol Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3389\/fimmu.2018.01295","article-title":"The emerging link between the complement cascade and purinergic signaling in stress hematopoiesis","volume":"9","author":"Ratajczak","year":"2018","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.12.013","article-title":"Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies","volume":"122","author":"Wang","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.03.018","article-title":"Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia","volume":"18","author":"Carey","year":"2017","journal-title":"Cell Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041480305","article-title":"Interleukin-6 production by the blast cells of acute myeloblastic leukemia: Regulation by endogenous interleukin-1 and biological implications","volume":"148","author":"Beauchemin","year":"1991","journal-title":"J Cell Physiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910460525","article-title":"Interleukin-1 and interleukin-2 control granulocyte-and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia","volume":"46","author":"Cozzolino","year":"1990","journal-title":"Int J Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114186","article-title":"Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control","volume":"84","author":"Oster","year":"1989","journal-title":"J Clinic Investig"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a010607","article-title":"Interleukin 10 inhibits cytokine production of human AML cells","volume":"7","author":"Westermann","year":"1996","journal-title":"Annals Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"New England J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp Hematol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1146","article-title":"The impact of inflammation-induced tumor plasticity during myeloid transformation","volume":"12","author":"Yeaton","year":"2022","journal-title":"Cancer Discov"},{"key":"B68","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2174\/187152309789838975","article-title":"Chemistry, Anti-infective protective properties of S100 calgranulins","volume":"8","author":"Hsu","year":"2009","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738005","article-title":"The Journal of the American Society of Hematology, S100A9 induces differentiation of acute myeloid leukemia cells through TLR4","volume":"129","author":"Laouedj","year":"2017","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0397-9","article-title":"S100A9-induced overexpression of PD-1\/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes","volume":"33","author":"Cheng","year":"2019","journal-title":"Leuk"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0120602","DOI":"10.1371\/journal.pone.0120602","article-title":"Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400844","article-title":"Overexpression of tumor necrosis factor (TNF)-\u03b1 and interferon (IFN)-\u03b3 by bone marrow cells from patients with myelodysplastic syndromes","volume":"11","author":"Kitagawa","year":"1997","journal-title":"Leuk"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22880","article-title":"Chromosomes, and Cancer, Chromosomal instability upregulates interferon in acute myeloid leukemia","volume":"59","author":"Jin","year":"2020","journal-title":"Genes, Chromosomes and Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.03.002","article-title":"Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN\u03b3 signaling","volume":"28","author":"Hormaechea-Agulla","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.355","article-title":"Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents","volume":"28","author":"Yang","year":"2014","journal-title":"Leuk"},{"key":"B77","article-title":"Effect of recombinant interferons on colony formation of blast progenitors in acute myeloblastic leukemia","volume":"15","author":"Takanashi","year":"1987","journal-title":"Exp Hematol"},{"key":"B78","article-title":"Differentiation-inducing effect of recombinant human tumor necrosis factor \u03b1 and \u03b3-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia","volume":"49","author":"Geissler","year":"1989","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003438","article-title":"Chronic exposure to a TLR ligand injures hematopoietic stem cells","volume":"186","author":"Esplin","year":"2011","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.11.031","article-title":"Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentiation","volume":"17","author":"Matatall","year":"2016","journal-title":"Cell Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leuk"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1030","article-title":"Hostile takeover: tregs expand in IFN\u03b3-rich AML microenvironment","volume":"28","author":"Ferrell","year":"2022","journal-title":"Clinical Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.180","article-title":"Toll-like receptor alterations in myelodysplastic syndrome","volume":"27","author":"Wei","year":"2013","journal-title":"Leuk"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2108","article-title":"Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes","volume":"13","author":"Maratheftis","year":"2007","journal-title":"Clinical Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.12.3932.h8003932_3932_3938","article-title":"The Journal of the American Society of Hematology, The role of apoptosis, proliferation, and the Bcl-2\u2013related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS","volume":"96","author":"Parker","year":"2000","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2010.01.009","article-title":"Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia","volume":"88","author":"Kuninaka","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00920-3","article-title":"High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic Malignancies","volume":"13","author":"Yuan","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-02011-9","article-title":"Chronic stress promotes acute myeloid leukemia progression through HMGB1\/NLRP3\/IL-1\u03b2 signaling pathway","volume":"99","author":"Liu","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1424","article-title":"NF-\u03baB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)","volume":"106","author":"Kerbauy","year":"2005","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-017-1023-1","article-title":"Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome","volume":"34","author":"de Matos","year":"2017","journal-title":"Med Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2301","article-title":"The Journal of the American Society of Hematology, Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210187","article-title":"NF-\u03baB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia","volume":"26","author":"Fabre","year":"2007","journal-title":"Oncogene"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-1962-x","article-title":"Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia","volume":"141","author":"Schrenk","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-083048","article-title":"The Journal of the American Society of Hematology, The novel AML stem cell\u2013associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells","volume":"110","author":"Van Rhenen","year":"2007","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/bjh.14270","article-title":"Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome","volume":"175","author":"Toft-Petersen","year":"2016","journal-title":"Br J Haematol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02613-7","article-title":"Complosome as a new intracellular regulatory network in both normal and Malignant hematopoiesis","volume":"39","author":"Ratajczak","year":"2025","journal-title":"Leuk"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci: Publ Protein Soc"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-215848","article-title":"Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease","volume":"115","author":"Akada","year":"2010","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.10.013","article-title":"Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling","volume":"18","author":"Chen","year":"2010","journal-title":"Cancer Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201544","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"218","author":"Trowbridge","year":"2021","journal-title":"J Exp Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.exphem.2019.12.005","article-title":"Environmental influences on clonal hematopoiesis","volume":"83","author":"King","year":"2020","journal-title":"Exp Hematol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"102673","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"mutations and cancer","volume":"83","author":"Kay","year":"2019","journal-title":"DNA Repair"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0368-6","article-title":"Sequentially inducible mouse models reveal that Npm1 mutation causes Malignant transformation of Dnmt3a-mutant clonal hematopoiesis","volume":"33","author":"Loberg","year":"2019","journal-title":"Leuk"},{"key":"B105","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","article-title":"Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNgamma signaling","volume":"28","author":"Hormaechea-Agulla","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.09.015","article-title":"Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis","volume":"12","author":"Liao","year":"2022","journal-title":"Acta Pharm Sinica B"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba9304","article-title":"Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis","volume":"374","author":"Avagyan","year":"2021","journal-title":"Science"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02296-x","article-title":"Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis","volume":"57","author":"McLoughlin","year":"2025","journal-title":"Nat Genet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.28.587254","article-title":"Mesenchymal stromal cell senescence induced by Dnmt3a -mutant hematopoietic cells is a targetable mechanism driving clonal hematopoiesis and initiation of hematologic Malignancy","author":"Mistry","year":"2024","journal-title":"bioRxiv: preprint server Biol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0086","article-title":"Distinct tumor necrosis factor alpha receptors dictate stem cell fitness versus lineage output in Dnmt3a-mutant clonal hematopoiesis","volume":"12","author":"SanMiguel","year":"2022","journal-title":"Cancer Discov"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0125-z","article-title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","volume":"557","author":"Meisel","year":"2018","journal-title":"Nat"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220962","article-title":"Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs","volume":"220","author":"Yokomizo-Nakano","year":"2023","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.bcd-22-0172","article-title":"Microbiota influences on hematopoiesis and blood cancers: new horizons","volume":"4","author":"Galloway-Pena","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08938-8","article-title":"Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1","volume":"642","author":"Agarwal","year":"2025","journal-title":"Nat"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25620","article-title":"Maintenance therapy in AML: the past, the present and the future","volume":"94","author":"Molica","year":"2019","journal-title":"Am J Hematol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-20-0871","article-title":"New trick: type I IFN\u2013based treatment for acute myeloid leukemiaType-I IFN in AML","volume":"19","author":"Alsufyani","year":"2021","journal-title":"Mol Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/nature07815","article-title":"IFN\u03b1 activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nat"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0692","article-title":"Interferon-\u03b1 Is effective for treatment of minimal residual\ndisease in patients with t (8; 21) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: results of a prospective registry study","volume":"23","author":"Mo","year":"2018","journal-title":"Oncologists"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1948027","article-title":"Interferon-\u03b1 as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia","volume":"62","author":"Jiang","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.078","article-title":"Transplantation, A Phase I\/II clinical trial of type 1 interferon for reduction of relapse after HCT in high risk AML","volume":"25","author":"Magenau","year":"2019","journal-title":"Blood Advances"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/biomedicines9111631","article-title":"Innate immune mechanisms and immunotherapy of myeloid Malignancies","volume":"9","author":"Small","year":"2021","journal-title":"Biomedicines"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.023","article-title":"STING pathway activation stimulates potent immunity against acute myeloid leukemia","volume":"15","author":"Curran","year":"2016","journal-title":"Cell Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci Transl Med"},{"key":"B125","first-page":"1083","article-title":"First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia","volume":"8","author":"Tang","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00246-w","article-title":"Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany","volume":"28","author":"Albinger","year":"2021","journal-title":"Gene Therapy"},{"key":"B127","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","article-title":"Targeting macrophages in hematological Malignancies: recent advances and future directions","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.293","article-title":"The role of TLR8 signaling in acute myeloid leukemia differentiation","volume":"29","author":"Ignatz-Hoover","year":"2015","journal-title":"Leukemia"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.166","article-title":"Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors","volume":"46","author":"Elmaagacli","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B130","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1182\/blood-2021-151511","article-title":"Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts","volume":"138","author":"Ellegast","year":"2021","journal-title":"Cancer Discov"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900885","article-title":"Activation of the intracellular pattern recognition receptor NOD2 promotes acute myeloid leukemia (AML) cell apoptosis and provides a survival advantage in an animal model of AML","volume":"204","author":"Buteyn","year":"2020","journal-title":"J Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05692-z","article-title":"TET2 guards against unchecked BATF3-induced CAR T cell expansion","volume":"615","author":"Jain","year":"2023","journal-title":"Nat"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02397-2","article-title":"Clonal hematopoiesis is associated with protection from Alzheimer\u2019s disease","volume":"29","author":"Bouzid","year":"2023","journal-title":"Nat Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.stem.2025.06.006","article-title":"TET2-mutant myeloid cells mitigate Alzheimer\u2019s disease progression via CNS infiltration and enhanced phagocytosis in mice. Cell stem cell","volume":"32","author":"Matatall","year":"2025","journal-title":"Cell Stem Cell"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2507106","article-title":"Tumor-infiltrating clonal hematopoiesis","volume":"393","author":"Spetzler","year":"2025","journal-title":"New Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:17:28Z","timestamp":1760588248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":135,"alternative-id":["10.3389\/fimmu.2025.1660709"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1660709","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"article-number":"1660709"}}